These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Airway Inflammation and Host Responses in the Era of CFTR Modulators. Keown K; Brown R; Doherty DF; Houston C; McKelvey MC; Creane S; Linden D; McAuley DF; Kidney JC; Weldon S; Downey DG; Taggart CC Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887484 [TBL] [Abstract][Full Text] [Related]
17. The NF-kappaB signaling in cystic fibrosis lung disease: pathophysiology and therapeutic potential. Bodas M; Vij N Discov Med; 2010 Apr; 9(47):346-56. PubMed ID: 20423679 [TBL] [Abstract][Full Text] [Related]
18. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis. Stotland PK; Radzioch D; Stevenson MM Pediatr Pulmonol; 2000 Nov; 30(5):413-24. PubMed ID: 11064433 [TBL] [Abstract][Full Text] [Related]
19. End-stage cystic fibrosis lung disease is characterised by a diverse inflammatory pattern: an immunohistochemical analysis. Lammertyn EJ; Vandermeulen E; Bellon H; Everaerts S; Verleden SE; Van Den Eynde K; Bracke KR; Brusselle GG; Goeminne PC; Verbeken EK; Vanaudenaerde BM; Dupont LJ Respir Res; 2017 Jan; 18(1):10. PubMed ID: 28069067 [TBL] [Abstract][Full Text] [Related]